Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Expected to Rise, Citigroup Analyst Says
Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report) had its target price lifted by analysts at Citigroup from $20.00 to $24.00 in a report issued on Thursday,Benzinga reports. The firm presently has a “neutral” rating on the medical device company’s stock. Citigroup’s target price would indicate a potential upside of 15.83% from the stock’s previous […]
Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report) had its target price lifted by analysts at Citigroup from $20.00 to $24.00 in a report issued on Thursday,Benzinga reports. The firm presently has a “neutral” rating on the medical device company’s stock. Citigroup’s target price would indicate a potential upside of 15.83% from the stock’s previous […]
